MSTN and Cachexia: In the past decades, strategies for cachexia therapy mainly focused on the development of new drugs, including ghrelin and ghrelin receptor agonists, myostatin antagonists, inflammatory cytokine neutralizing antibodies, and natural product extracts [28–37].